OKLO Builds on Groves Progress to Expand Isotope Business
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Oklo Inc. (OKLO) is advancing its domestic isotope supply chain through its Groves-1 Isotope Test Reactor in Texas, which achieved first criticality in just over 11 months. This facility will support the production of isotopes for cancer treatments, manufacturing, and research, with management planning to apply lessons learned to future projects.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.